In addition to the fact that SqD and the basal-squamous subtype has been associated with enhanced overall survival following neoadjuvant chemotherapy and cystectomy35, TFAP2A was previously identified as an independent predictor of good response to cisplatin treatment in BC patients36. Here, TFAP2A is linked to breast cancer.